Steven Cohen Spectrum Pharmaceuticals Inc Put Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $4.02 Million - $5.77 Million	-250,000 Reduced 31.25%	550,000 $8.85 Million
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $10.7 Million - $16.6 Million	800,000	800,000 $15.2 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.